HAL (France)
open access
Alpha-1 Antitrypsin Deficiency Alleles in Non-Cirrhotic Hepatocellular Carcinoma: Insights from a Multicenter French Cohort
Background and aims: Patients with alpha-1 antitrypsin deficiency (AATD) have a 20-to 50-fold higher risk of developing primary liver cancer (PLC), such as hepatocellular carcinoma (HCC), in both cirrhotic and noncirrhotic livers, highlighting AATD as a potential oncogenic factor. In this explorator
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prevalence of Alpha-1 Antitrypsin Deficiency in Non-Cirrhotic Liver Cancer#1088749
- Natural Course and Molecular Basis of Alpha 1- Antitrypsin Deficiency-associated Liver Disease.#992198
- Genotypic diversity and phenotypic spectrum of infantile liver failure syndrome type 1 due to variants in LARS1#322548
- Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025#366646
- PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.#234508
Record · ID 1166421
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive